OQROStart free trial
Politician trade (House)

Johnson & Johnson (JNJ): Rep. Kevin Hern (OK01) disclosed a purchase $1K–$15K

Rep. Kevin Hern (OK01) disclosed a purchase of Johnson & Johnson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
38 days
Disclosure lag
Traded
Mar 5, 2024
Disclosed
Apr 12, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 5, 2023Congress · 2 peopleMembers of Congress: 2 purchases
  2. Dec 14, 2023Congress · 1 personMembers of Congress: 2 sales
  3. Jan 19, 2024Congress · 1 personMembers of Congress: 2 sales
  4. Jan 23, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Mar 5, 2024 · this disclosureCongressDisclosed purchase of JNJ — reported range $1,001 - $15,000

What came next

  1. Mar 5, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. May 10, 2024FDARecall: PDS Plus Antibacterial (polydioxanone) Suture - Intended for use in general soft tissue approximation, including use in paediatric cardiovascular tissue, in mi…
  3. May 10, 2024FDARecall: MONOCRYL (poliglecaprone 25) Suture - Intended for use in general soft tissue approximation and/or ligation where an absorbable material is indicated PRODUCT C…
  4. May 10, 2024FDARecall: VICRYL (polyglactin 910) Suture - Indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic surgery, but not for use…
  5. May 31, 2024FDARecall: Impella CP with SmartAssist, Product No.: 1000080 (REF 0048-0003). left heart support blood pump
  6. Jun 4, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  7. Jun 5, 2024FDAFDA device clearance: VELYS Robotic-Assisted Solution
  8. Jun 11, 2024FDARecall: SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM), Product Number: 1961
  9. Jun 11, 2024FDARecall: SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM), Product Number: 1963
  10. Jun 12, 2024FDAFDA device clearance: SOUNDSTAR™ CRYSTAL Ultrasound Catheter
  11. Jun 14, 2024FDAFDA device clearance: TELIGEN System Navigation Ready Instruments
  12. Jun 17, 2024FDAFDA device clearance: CROSSNAV Navigation Enabled Instruments
  13. Jun 17, 2024FDAFDA device clearance: Robotic Integration Instruments
  14. Jun 18, 2024FDAFDA device clearance: ATTUNE® Porous Fixed Bearing Tibial Base, Medialized Dome Patella and Medialized Anatomic Patella with AFFIXIUM 3DP Technology
  15. Jun 21, 2024FDAFDA drug approval: Sirturo
  16. Jun 28, 2024FDAFDA device clearance: NUVISION™ Ultrasound Catheter; NUVISION™ NAV Ultrasound Catheter
  17. Jul 3, 2024FDAFDA device clearance: ECHELON 3000 45mm Compact Stapler (ECH45C); Echelon 3000 45mm Standard Stapler (ECH45S); Echelon 3000 45mm Long Stapler (ECH45L); Echelon 3000 60mm Compact Sta…
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Kevin Hern (OK01)

The full history of Rep. Kevin Hern (OK01) is on the profile page.

How this filing works

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data